Effectiveness and Safety of Ibrutinib for Chronic Lymphocytic Leukemia in Routine Clinical Practice: 3-Year Follow-up of the Belgian Ibrutinib Real-World Data (BiRD) Study

The multicenter observational BiRD study investigated the real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL) and Waldenström’s macroglobulinemia (WM) in Belgium. This interim analysis reports results for patients with CLL,...

Descripción completa

Detalles Bibliográficos
Autores principales: Janssens, Ann, Berneman, Zwi N., Offner, Fritz, Snauwaert, Sylvia, Mineur, Philippe, Vanstraelen, Gaetan, Meers, Stef, Spoormans, Isabelle, Bron, Dominique, Vande Broek, Isabelle, Van Bogaert, Charlotte, De Beleyr, Birgit, Smet, Ann, Nielsen, Lasse, Wapenaar, Robert, André, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763520/
https://www.ncbi.nlm.nih.gov/pubmed/36227519
http://dx.doi.org/10.1007/s44228-022-00020-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763520/
https://www.ncbi.nlm.nih.gov/pubmed/36227519
http://dx.doi.org/10.1007/s44228-022-00020-8

Ejemplares similares